Ebby George Simon
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn's disease? A systematic review
Simon, Ebby George; Wardle, Richard; Thi, Aye Aye; Eldridge, Jeanette; Samuel, Sunil; Moran, Gordon William
Authors
Richard Wardle
Aye Aye Thi
Jeanette Eldridge
Sunil Samuel
GORDON MORAN GORDON.MORAN@NOTTINGHAM.AC.UK
Professor of Gastroenterology
Abstract
Fecal calprotectin (FC) is a highly sensitive disease activity biomarker in inflammatory bowel disease. However, there are conflicting reports on whether the diagnostic accuracy in Crohn’s disease is influenced by disease location. The aim of this study was to undertake a systematic review of the published literature. Relevant databases were searched from inception to November 8, 2016 for cohort and case control studies which had data on FC in patients with isolated small bowel (SB) and large bowel (LB) Crohn’s disease. Reference standards for disease activity were endoscopy, magnetic resonance imaging, computed tomography or a combination of these. The QUADAS-2 research tool was used to assess the risk of bias. There were 5,619 records identified at initial search. The 2,098 duplicates were removed and 3,521 records screened. Sixty-one full text articles were assessed for eligibility and 16 studies were included in the final review with sensitivities and specificities per disease location available from 8 studies. Sensitivities of FC at SB and LB locations ranged from 42.9% to 100% and 66.7% to 100% respectively while corresponding specificities were 50% to 100% and 28.6% to 100% respectively. The sensitivities and specificities of FC to accurately measure disease activity in Crohn’s disease at different disease locations are diverse and no firm conclusion can be made. Better studies need to be undertaken to categorically answer the effect of disease location on the diagnostic accuracy of FC.
Citation
Simon, E. G., Wardle, R., Thi, A. A., Eldridge, J., Samuel, S., & Moran, G. W. (2019). Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn's disease? A systematic review. Intestinal Research, 17(2), 160-170. https://doi.org/10.5217/ir.2018.00114
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 2, 2019 |
Online Publication Date | Feb 7, 2019 |
Publication Date | Apr 1, 2019 |
Deposit Date | Jan 21, 2019 |
Publicly Available Date | Jan 21, 2019 |
Journal | Intestinal Research |
Print ISSN | 1598-9100 |
Electronic ISSN | 2288-1956 |
Publisher | Korean Association for the Study of Intestinal Diseases |
Peer Reviewed | Peer Reviewed |
Volume | 17 |
Issue | 2 |
Pages | 160-170 |
DOI | https://doi.org/10.5217/ir.2018.00114 |
Public URL | https://nottingham-repository.worktribe.com/output/1483190 |
Publisher URL | https://www.irjournal.org/journal/view.php?doi=10.5217/ir.2018.00114 |
Contract Date | Jan 21, 2019 |
Files
faecal calprotectin
(437 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Clinical predictors of thiopurine-related adverse events in Crohn's disease
(2015)
Journal Article
Colectomy is a risk factor for venous thromboembolism in ulcerative colitis
(2015)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search